期刊文献+

肾小球滤过屏障超微结构改变与Alport综合征蛋白尿的关系 被引量:4

Relationship between ultrastructural lesions of glomerular filtration barrier and proteinuria in Alport syndrome
下载PDF
导出
摘要 目的:探讨肾小球滤过屏障超微结构改变与Alport综合征(AS)蛋白尿发生的关系。方法:AS患者35例,男24例,女11例,肾活检的年龄为1.17~24岁。根据尿蛋白结果将患者分为2组:无/间歇性蛋白尿组(13例)和持续性蛋白尿组(22例)。测量AS肾小球基底膜(GBM)变薄、增厚和致密层撕裂分层的长度,计算其各占GBM总长度的百分比;根据平均足突宽度(FPW)=π/4×(∑基底膜长度/∑足突个数)计算患者足突宽度。分析比较2组患者GBM变薄、增厚、致密层撕裂分层比例和平均FPW及其与AS蛋白尿的关系。结果:持续性蛋白尿组GBM增厚、致密层撕裂分层比例和平均FPW较无/间歇蛋白尿组高(均P<0.05)。平均FPW与GBM增厚、致密层撕裂分层及肾活检年龄均呈正相关(均P<0.01)。结论:AS患者GBM病变程度越重,足突融合越严重,蛋白尿越严重,提示AS基底膜异常有可能通过影响足突及裂孔膜的结构和功能导致蛋白尿发生。 AIM: To explore the relationship between the ultrastructural lesions of glomerular filtration barrier (GFB) and proteinuria in Alport syndrome (AS). METHODS: Thirty-five AS patients (24 males and 11 females), who were admitted to our hospital from 2008 to 2012, were enrolled in this study. The median age was 6 years ( 1.17 ~ 24 years) according to the time of renal biopsy. The data of clinical and electron microscopic examination were collected for retrospective analysis. The patients were divided into 2 groups according to the degree of urinary protein : non-/interval pro- teinuria group (13 cases) and persistent proteinuria group (22 cases). The length of glomerular basement membrane (GBM) attenuation, thickening, and dense layer splitting and layering was measured, and the percentages of these lesions were calculated. The foot process width (FPW) was measured according to the formula average FPW = 7r/4 x ( Y~ GBM length/~ foot process number). The differences of the ultrastructural lesions in GFB between the 2 groups were compared, and the association between GFB ultrastructural lesions and proteinuria were analyzed. RESULTS: The percentages of GBM thickening, splitting and layering were higher, and the foot processes were wider in persistent proteinuria group than those in non-/interval proteinuria group. The median age at renal biopsy in persistent proteinuria group was older than that in non-/interval proteinuria group. The average FPW of the 35 patients was positively correlated with the percentage of GBM thickening, splitting and layering, and the age at biopsy, respectively. CONCLUSION: The severity of GBM le- sions is associated with the severity of foot process damage and the severity of proteinuria, suggesting that foot process dam- age associated with proteinuria in AS may be secondary to GBM lesions.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第2期361-363,共3页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金资助项目(No.S2012010009405) 广东省科技计划(No.2011B031800126) 高校基本科研业务费中山大学青年教师培育项目(No.09ykpy40)
关键词 ALPORT综合征 肾小球基底膜 足细胞 蛋白尿 Alport syndrome Glomerular basement membrane Podocytes Proteinuria
  • 相关文献

参考文献9

  • 1管娜,丁洁,王素霞,黄建萍,刘景城.足细胞与Alport综合征蛋白尿的关系[J].中华肾脏病杂志,2010,26(10):748-752. 被引量:6
  • 2Gubler MC. Inherited diseases of the glomerular basement membrane[J].Nephrology,2008,(01):24-37.
  • 3Abrahamson DR,Isom K,Roach E. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects[J].Journal of the American Society of Nephrology,2007,(09):2465-2472.doi:10.1681/ASN.2007030328.
  • 4梁燕,程丽静,黄海长.足细胞损伤与肾小球疾病[J].中国病理生理杂志,2005,21(9):1864-1866. 被引量:6
  • 5Gagliardini E,Conti S,Benigni A. Imaging of the porous ultrastructure of the glomerular epithelial filtration slit[J].Journal of the American Society of Nephrology,2010,(12):2081-2089.
  • 6White RH,Raafat F,Milford DV. The Alport nephropathy:clinicopathological correlations[J].Pediatric Nephrology,2005,(07):897-903.
  • 7Haas M. Alport syndrome and thin glomerular basement membrane nephropathy:a practical approach to diagnosis[J].Archives of Pathology and Laboratory Medicine,2009,(02):224-232.
  • 8Gong W,Liu Z,Chen H. Spectrum of clinical features and type IV collagen α-chain distribution in Chinese patients with Alport syndrome[J].Nephrology Dialysis Transplantation,2006,(11):3146-3154.
  • 9Hamano Y,Grunkemeyer JA,Sudhakar A. Determinants of vascular permeability in the kidney glomerulus[J].Journal of Biological Chemistry,2002,(34):31154-31162.

二级参考文献32

  • 1邢燕,丁洁,范青锋,管娜.足细胞分子高表达致阿霉素肾病大鼠发生蛋白尿[J].中华肾脏病杂志,2006,22(1):27-32. 被引量:39
  • 2范青锋,邢燕,丁洁.足细胞裂孔隔膜与信号传导[J].中华肾脏病杂志,2006,22(5):312-315. 被引量:5
  • 3Ricardo SD, Bertram JF, Ryan GB. Antioxidants protect podocyte foot proceses in puromycin anionucleoside-treated rats[J]. J Am Soc Nephrol, 1994, 4(12): 1974-1986.
  • 4Endlich N, Kress KR, Reiser J, et al. Podocytes respond to mechanical stress in vitro[J]. J Am Soc Nephrol, 2001, 12(3): 413-422.
  • 5Durvasula RV, Petermann AT, Hiromura K, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain[J]. Kidney Int, 2004, 65(1): 30-39.
  • 6Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells[J]. Am J Renal Physiol, 2002, 283(1): F173-F180.
  • 7Sanwal V, Pandya M, Bhaskaran M, et al. Puromycin aminonucleoside induces glomerular epithelial cell apoptosis[J]. Epxt Mol Path, 2001, 70(1): 54-64.
  • 8Schiffer M, Schiffer LE, Gupta A, et al. Inhibitory smads and TGF-? bsignaling in glomerular cells[J]. J Am Soc Nephrol, 2002, 13(11): 2657-2666.
  • 9Kim YH, Goyal M, Kurnit D, et al. Podocyte depletion and glomerulosclerosis have a relationship in the PAN-treated rat[J]. Kidney Int, 2001, 60(3): 957-968.
  • 10Hara M, Yanagihar T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis[J]. Nephron, 2001, 89(3): 342-347.

共引文献10

同被引文献40

  • 1潘晓霞,陈楠,史浩,任红,陈晓农,周伟,倪莉燕,张文,吴开胤,王朝晖.Alport综合征患者肾组织层粘连蛋白α2链异常分布[J].中华肾脏病杂志,2005,21(7):380-383. 被引量:1
  • 2马序竹,张宏,王素霞,陈育青,侯平,吕继成,王海燕.IgA肾病合并肾小球基底膜弥漫性变薄的临床特点及COL4A3/COL4A4的基因连锁分析[J].中华肾脏病杂志,2006,22(5):261-265. 被引量:19
  • 3Srinivasan M,Uzel S G,Gautieri A,et al.Alport syndrome mutations in type IV tropocollagen alter molecular structure and nanomechanical properties[J].J Struct Biol,2009,168(3):503-510.
  • 4Flinter F.Alport's syndrome[J].J Med Genet,1997,34(4):326-330.
  • 5Alves F R,de A Q R F.Revision about hearing loss in the Alport's syndrome,analyzing the clinical,genetic and bio-molecular as pects[J].Braz J Otorhinolaryngol,2005,71(6):813-819.
  • 6Alves F R,Ribeiro F A.Clinical data and hearing of individuals with Alportsyndrome[J].Braz J Otorhinolaryngol,2008,74(6):807-814.
  • 7Moon I S,Bang M Y,Shim D B,et al.Severe to profound hearing loss in patients with progressed Alport's syndrome[J].Acta Otolaryngol,2009,129(9):982-987.
  • 8Pittman A L,Stelmachowicz P G.Hearing loss in children and adults:audiometric configuration,asymmetry,and progression[J].Ear Hear,2003,24(3):198-205.
  • 9Lutman M E,Coles R R.Asymmetric sensorineural hearing thresholds in the non-noise-exposed UK population:a retrospective analysis[J].Clin Otolaryngol,2009,34(4):316-321.
  • 10Bekheirnia M R,Reed B,Gregory M C,et al.Genotype-phenotype correlation in X-linked Alport syndrome[J].J Am Soc Nephrol,2010,21(5):876-883.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部